Subgroups in Fibromyalgia
Mechanisms
of Pain in Patients with the
Fibromyalgia Syndrome
Roland Staud, M.D., Division of Rheumatology and Clinical Immunology
University of Florida, Gainesville, FL 32610
Introduction:
Fibromyalgia Syndrome (FMS) is characterized by chronic widespread pain
associated with allodynia. Our experiments with FMS subjects have indicated
abnormalities of second pain in these patients which are related to central
N-methyl-D-aspartate (NMDA) receptor processing. Our basic hypothesis
is that abnormal central pain processing of second pain in FMS subjects
is one of the fundamental abnormalities in this syndrome. Second pain
results from impulse conduction in peripheral C (unmyelinated) afferent
axons and is particularly sensitive to inhibition by opioid compounds.
Second pain also increases in intensity when stimuli are applied more
often than once every three seconds and this summation has been hypothesized
to result from a central NMDA receptor mechanism. First pain is related
to stimulation of A-Delta (myelinated) nociceptors and has been utilized
almost exclusively to evaluate pain sensitivity. In order to compare directly
abnormal processing of A-Delta and C-Fiber input in FMS subjects, we have
utilized forms of brief experimental pain stimuli that can reliably evoke
perceptions of first and second pain when applied
to the hand or foot of human subjects.
RESULTS: Ten FMS patients and ten healthy age and sex matched
controls were studied. The FMS subjects rated their level of pain, fatigue,
and stiffness up to 30 times higher than control subjects. The average
number of tender points was 16 for FMS patients and 1 for healthy controls,
respectively. The rating of 2nd pain by FMS patients and control subjects
using trains of 10, 15, or 20 stimuli at the fast interstimulatory interval
of 2 seconds exceeded pain threshold on their first stimulation, and wound
up more than three times compared to normal controls. At the slow speed
of stimulation of 5 second ISI, normal controls consistently stayed below
pain threshold after 10 or 15 stimulations. In contrast, FMS patients
reported again pain on first stimulation and showed increasing pain even
after 10 and 15 stimulations. FMS patients also showed a 40% Wind-up at
this low frequency ISI.
These
results indicate that FMS patients show excessive summation of second
pain at 2 second ISI thermal stimulation and abnormal wind-up at 5 second
ISI. Abnormal central pain processing in patients with FMS can lead to
central sensitization which may be an important mechanism of chronic pain
in this frequent and often disabling syndrome.
FMS
is a generalized muscular pain disorder which characteristically
worsens with physical activity. Because exercise has been sown to activate
endogenous opioid and noradrenergic pain inhibitory systems we hypothesized
that these pain modulatory systems may be compromised in FMS patients.
We therefore compared the effects of exercise on different forms of pain
sensitivity for fibromyalgia patients and matched normal controls.
Methods:
We tested wind-up in ten FMS subjects matched to controls after exercise
at V02 max. All subjects exercised to maximal exertion on a treadmill
using the BRUCE protocol. The perceived level of exertion was tested every
3 minutes. V02 max, MET, RER were measured. Wind-up was tested with a
Peltier device using numerical ratings of late sensations of pain after
brief (700 ms) contact of the preheated thermode with the palmar skin
of either hand. The interval between stimuli (ISI) varied between 2 and
5 sec. After each exercise session, wind-up was tested daily over 4 days
and daily VAS pain questionnaires were completed by all subjects. Compared
to baseline, exercise increased the 1st response to heat stimulation in
FMS subjects and prolonged its after-effect, whereas max response remained
unchanged. VAS of pain after exercise also remained unchanged over the
next 96 h. In contract, controls showed decrease in all parameters of
wind-up.
Conclusion: We conclude
that wind-up of FMS subjects after exercise is abnormal and reflects the
lack of pain improvement seen in FMS subjects after physical exertion.
Presented at the National Fibromyalgia
Research Association's Subgroups in Fibromyalgia Symposium, September
26-27, 1999, in Portland, Oregon.